JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB151751

Anti-SLC17A1 antibody [EPR9614]

Be the first to review this product! 리뷰 제출

|

(1 출판물)

Rabbit Recombinant Monoclonal SLC17A1 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.

대체 명칭 보기

NPT1, SLC17A1, Sodium-dependent phosphate transport protein 1, Na(+)/PI cotransporter 1, Na/Pi-4, Renal Na(+)-dependent phosphate cotransporter 1, Renal sodium-dependent phosphate transport protein 1, Sodium/phosphate cotransporter 1, Solute carrier family 17 member 1, Renal sodium-phosphate transport protein 1

1 이미지
Western blot - Anti-SLC17A1 antibody [EPR9614] (AB151751)
  • WB

Unknown

Western blot - Anti-SLC17A1 antibody [EPR9614] (AB151751)

All lanes:

Western blot - Anti-SLC17A1 antibody [EPR9614] (ab151751) at 1/1000 dilution

All lanes:

Human fetal kidney lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP

Predicted band size: 51 kDa

false

관련 conjugated 항체와 다양한 조성의 항체 (1)

  • Carrier free

    Anti-SLC17A1 antibody [EPR9614] - BSA and Azide free

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR9614

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

보완 제품

Primary Antibodies

AB137103

Anti-NAT14 antibody [EPR9376]

RabMAb|Recombinant

Western blot - Anti-NAT14 antibody [EPR9376] (AB137103)

  • 0
  • 6
Primary Antibodies

AB139408

Anti-IKZF3 antibody [EPR9342(B)]

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IKZF3 antibody [EPR9342(B)] (AB139408)

  • 0
  • 0
Primary Antibodies

AB150389

Anti-NAB1 antibody [EPR8227(2)]

RabMAb|Recombinant

Western blot - Anti-NAB1 antibody [EPR8227(2)] (AB150389)

  • 1
  • 1
Primary Antibodies

AB154182

Anti-AMPS antibody [EPR10747(B)]

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AMPS antibody [EPR10747(B)] (AB154182)

  • 0
  • 0
style
left-column

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }
style
left-column

제품 세부 정보

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

특성 및 보관 정보

제형
Liquid
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
style
left-column

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

SLC17A1 also known as NPT1 or sodium-dependent phosphate transport protein 1 is a protein that functions primarily as a transporter. It facilitates the reabsorption of phosphate ions in the renal proximal tubules. This protein has a molecular mass of approximately 54 kDa and is mainly expressed in the kidney. The presence of SLC17A1 in renal tissues plays an important role in maintaining plasma phosphate levels which is essential for bone health and various metabolic processes. Additionally SLC17A1 belongs to the solute carrier family 17 acting as an important mediator in phosphate homeostasis.
Biological function summary

This transporter plays a significant role in the regulation of phosphate balance in the body. By functioning in the renal system SLC17A1 affects phosphate excretion and reabsorption which directly influences mineral and bone metabolism. It operates as part of a greater network involving other phosphate transporters and channels in the kidney. This network ensures that the body maintains proper phosphate levels necessary for critical cellular functions and skeletal integrity. The efficient operation of SLC17A1 in this context is essential to the homeostatic maintenance of serum phosphate concentrations.

Pathways

SLC17A1 is an important component of phosphate homeostasis and mineral metabolism pathways. It interacts with other proteins such as SLC34A1 another sodium-dependent phosphate transporter and plays a part in the renal tubular reabsorption of phosphate. These pathways are vital in regulating the levels of phosphate which is integral for energy production nucleotide synthesis and signaling processes in cells. The transporter collaborates with other elements in the parathyroid hormone-related pathways impacting overall calcium homeostasis and bone remodeling.

SLC17A1 is closely linked to conditions such as phosphate wasting disorders and renal tubular reabsorption abnormalities. Mutations or dysfunctions in the SLC17A1 gene may lead to diseases like hypophosphatemia characterized by low serum phosphate levels and associated bone disorders such as rickets and osteomalacia. The protein's involvement in these conditions often overlaps with interactions alongside other transport proteins like SLC20A1 affecting phosphate absorption and systemic phosphate balance. Understanding this relationship is important for developing therapeutic strategies aimed at treating phosphate-related disorders.
style
left-column
style
left-column

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

타겟 정보

Important for the resorption of phosphate by the kidney (PubMed : 7826357). May be involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane (PubMed : 7826357). Plays a role in urate transport in the kidney (PubMed : 25252215, PubMed : 27906618).
See full target information SLC17A1
style
left-column

제품이 사용된 논문 (1)

Recent publications for all applications. Explore the 전체 목록 and refine your search

PLoS genetics 16:e1009176 PubMed33137164

2020

Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Emily M Schleicher,Ashna Dhoonmoon,Lindsey M Jackson,Kristen E Clements,Coryn L Stump,Claudia M Nicolae,George-Lucian Moldovan
제품이 사용된 논문 모두 보기
style
left-column
style
left-column
style
right-column

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com